We get down to brass tacks with the many Categorised Controlled Drugs within the Sanctuary of the UK, and inform you, the reader, of what is…and what isn’t.

Drugs controlled by the United Kingdom (UK) Misuse of Drugs Act 1971 are listed in this article.

These drugs are usually known in the UK as controlled drugs, because they are such by the meaning given to that term by the act itself. In more general terms, however, many of these drugs are also controlled by the Medicines Act 1968, and there are many other drugs which are controlled by the Medicines Act but not by the Misuse of Drugs Act.

The Misuse of Drugs Act sets out three separate categories, Class A, Class B, and Class C. Class A drugs represent those deemed most dangerous, and so carry the harshestpunishments. Class C represents those thought to have the least capacity to harm, and so the Act demands more lenient punishment. Being found in possession of a drug on this list is dealt with less seriously than would be if it were deemed that there is intent to supply the drug to others. Possession with intent to supply carries a maximum penalty of life imprisonment.

With regards to lawful possession and supply, a different set of categories apply which are set out in the Misuse of Drugs Regulations 2001 (as amended). This sets out five schedules each with their own restrictions. Schedule 1 contains substances with no medicinal value such as hallucinogens and their use is limited primarily to research, whereas schedules 2-5 contain the other regulated drugs. This means that although drugs may fall into the category of Class A/B/C, they may also fall into one of the schedules for legitimate medicinal use. For example, morphine is a Class A drug under the Misuse of Drugs Act 1971, but when lawfully supplied falls under the category of a Schedule 2 controlled drug.

Substances may be removed and added to different parts of the schedule by statutory instrument, provided a report of the Advisory Council on the Misuse of Drugs has been commissioned and has reached a conclusion, although the Secretary of State is not bound by the council’s findings. This list has in practice modified a great number of times, sometimes removing substances, but more commonly adding some; for example, many benzodiazepines became Class C drugs in 1985.

Glossary of terminology used in this list


anabolic steroids — hormones that build muscle tissue
benzodiazepines — sedatives with calming properties
cannabinoids — drugs that bind to cannabinoid receptors
hallucinogens — drugs that alter perception of reality
opioids — sedatives that relieve pain (but are highly addictive)
phenethylamines — hallucinogens based on phenethylamine
sedatives — drugs that lower consciousness
stimulants — drugs that heighten consciousness
tryptamines — hallucinogens based on tryptamine

Contents

Class A drugs

1. The following substances, namely:-

(a)

Name as specified
in the Act↓
Predominant
street name↓
Drug type↓ When
added
↓
Notes and comments↓
Acetorphine opioid 1971 primarily used to sedate elephants, giraffes and rhinos
Alfentanil opioid 1984
Allylprodine opioid 1971
Alphacetylmethadol ? 1971
Alphameprodine opioid 1971
Alphamethadol opioid 1971
Alphaprodine opioid 1971
Anileridine opioid 1971
Benzethidine opioid 1971
Benzylmorphine opioid 1971
Betacetylmethadol ? 1971
Betameprodine opioid 1971
Betamethadol opioid 1971
Betaprodine opioid 1971
Bezitramide opioid 1971
Bufotenine Toad tryptamine 1971 found in the psychoactive toads
Carfentanil opioid 1986 Used as a tranquilizer for large game (elephants etc.)
Clonitazene opioid 1971
Coca leaf Erythroxylum 1971 the plant from which cocaine is derived
Cocaine coke stimulant 1971 one of the most widely used illicit drugs in the world
Desomorphine opioid 1971
Dextromoramide opioid 1971
Diamorphine heroin opioid 1971 derivative of the opium poppy
Diampromide opioid 1971
Diethylthiambutene opioid 1971
Difenoxin opioid 1975
Dihydrocodeinone O-carboxymethyloxime opioid 1971
Dihydroetorphine 2003
Dihydromorphine opioid 1971
Dimenoxadole ? 1971
Dimepheptanol opioid 1971 an analogue of methadone
Dimethylthiambutene opioid 1971
Dioxaphetyl butyrate opioid 1971
Diphenoxylate opioid 1971
Dipipanone opioid 1971
Drotebanol opioid 1973
Ecgonine precursor 1971 “and any derivative of ecgonine which is convertible to ecgonine or to cocaine”
Ethylmethylthiambutene opioid 1971
Eticyclidine hallucinogen 1984
Etonitazene opioid 1971
Etorphine opioid 1971
Etoxeridine opioid 1971
Etryptamine tryptamine 1998
Fentanyl opioid 1971 81 times more potent than morphine
Furethidine opioid 1971
Hydrocodone vicodin opioid 1971
Hydromorphinol opioid 1971
Hydromorphone opioid 1971
Hydroxypethidine opioid 1971
Isomethadone ? 1971
Ketobemidone opioid 1971
Levomethorphan opioid 1971
Levomoramide opioid 1971 the totally inactive isomer of dextromoramide
Levophenacylmorphan opioid 1971
Levorphanol opioid 1971
Lofentanil opioid 1986
Lysergamide ergoline 1971 a precursor to LSD
Lysergic acid diethylamide LSD, acid ergoline 1971 “Lysergide and other N-alkyl derivatives of lysergamide”
Mescaline mescaline phenethylamine 1971 found naturally in the peyote cactus
Metazocine opioid 1971
Methadone methadone opioid 1971
Methadyl acetate opioid 1971 used in treating opioid addiction, structurally related to methadone
Methamphetamine crystal meth stimulant 2006 moved from class B to class A in 2006
Methyldesorphine opioid 1971
Methyldihydromorphine opioid 1971
MDMA ecstasy phenethylamine 1977 [citation needed]
Metopon opioid 1971
Morpheridine opioid 1971
Morphine morphine opioid 1971 widely used clinical painkiller
Morphine methobromide ? 1971 morphine N-oxide and other pentavalent nitrogen morphine derivatives”
Myrophine opioid 1971
Nicomorphine opioid 1971
Noracymethadol ? 1971
Norlevorphanol ? 1971
Normethadone opioid 1971
Normorphine opioid 1971
Norpipanone ? 1971
Opium opium opioid mixture 1971 milky secretion of the opium poppy – banned “whether raw, prepared or medicinal”
Oxycodone OC, OxyCotton opioid 1971 Widely used strong pain killer, notorious for abuse
Oxymorphone opioid 1971
Pethidine opioid 1971
Phenadoxone opioid 1971
Phenampromide opioid 1971
Phenazocine opioid 1971
Phencyclidine angel dust, PCP (getting wet) hallucinogen 1979
Phenomorphan opioid 1971
Phenoperidine opioid 1971
Piminodine opioid 1971
Piritramide opioid 1971
Poppy-straw Papaver somniferum 1971 “Poppy-straw and concentrate of poppy-straw.”
Proheptazine opioid 1971
Properidine opioid 1971
Psilocin tryptamine 1971 found in most psychedelic mushrooms
Psilocybe mushrooms magic mushrooms fungi 2005 “Fungus (of any kind) which contains psilocin or an ester of psilocin.”
Racemethorphan opioid mixture 1971
Racemoramide opioid mixture 1971
Racemorphan opioid mixture 1971
Remifentanil 2003 [2] Strong painkiller; cannot be used without plasma infusion equipment
Rolicyclidine hallucinogen 1984
Sufentanil opioid 1983
Tenocyclidine hallucinogen 1984
Thebacon opioid 1971
Thebaine opioid 1971
Tilidate opioid 1983
Trimeperidine opioid 1971
2,5-Dimethoxy-4-bromoamphetamine DOB phenethylamine 1975 a drug of the 2C family
4-Cyano-2-dimethylamino-4,4-diphenylbutane ? 1971
4-Cyano-1-methyl-4-phenyl-piperidine ? 1971
N,N-Diethyltryptamine tryptamine 1971
N,N-Dimethyltryptamine tryptamine 1971
2,5-Dimethoxy-4-methylamphetamine DOM phenethylamine 1971 a drug of the 2C family
N-Hydroxy-tenamphetamine ? 1990
1-Methyl-4-phenylpiperidine-4-carboxylic acid precursor 1971
2-Methyl-3-morpholino-1 ? 1971
1-diphenylpropanecarboxylic acid ? 1971
4-Methyl-aminorex ice stimulant 1990
4-Phenylpiperidine-4-carboxylic acid ethyl ester ? 1971
N.B. Sub-paragraphs (b) and (c) were added in 1977, sub-paragraphs (d) and (e) were added in 1986. Sub-paragraph (ba) was subsequently added in 2001.

(b) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from tryptamine or from a ring-hydroxy tryptamine by substitution at the nitrogen atom of the sidechain with one or more alkyl substituents but no other substituent;

(ba) the following phenethylamine derivatives, namely:—

  • Allyl(a-methyl-3,4-methylenedioxyphenethyl)amine
  • 2-Amino-1-(2,5-dimethoxy-4-methylphenyl)ethanol
  • 2-Amino-1-(3,4-dimethoxyphenyl)ethanol
  • Benzyl(a-methyl-3,4-methylenedioxyphenethyl)amine
  • 4-Bromo-b,2,5-trimethoxyphenethylamine
  • N-(4-sec-Butylthio-2,5-dimethoxyphenethyl)hydroxylamine
  • Cyclopropylmethyl(a-methyl-3,4-methylenedioxyphenethyl)amine
  • 2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)ethylamine
  • 2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)-1-methylethylamine
  • 2-(2,5-Dimethoxy-4-methylphenyl)cyclopropylamine
  • 2-(1,4-Dimethoxy-2-naphthyl)ethylamine
  • 2-(1,4-Dimethoxy-2-naphthyl)-1-methylethylamine
  • N-(2,5-Dimethoxy-4-propylthiophenethyl)hydroxylamine
  • 2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)ethylamine
  • 2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)-1-methylethylamine
  • a,a-Dimethyl-3,4-methylenedioxyphenethylamine
  • a,a-Dimethyl-3,4-methylenedioxyphenethyl(methyl)amine
  • Dimethyl(a-methyl-3,4-methylenedioxyphenethyl)amine
  • N-(4-Ethylthio-2,5-dimethoxyphenethyl)hydroxylamine
  • 4-Iodo-2,5-dimethoxy-a-methylphenethyl(dimethyl)amine
  • 2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)ethylamine
  • 2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)-1-methylethylamine
  • 2-(5-Methoxy-2,2-dimethyl-2,3-dihydrobenzo[b]furan-6-yl)-1-methylethylamine
  • 2-Methoxyethyl(a-methyl-3,4-methylenedioxyphenethyl)amine
  • 2-(5-Methoxy-2-methyl-2,3-dihydrobenzo[b]furan-6-yl)-1-methylethylamine
  • b-Methoxy-3,4-methylenedioxyphenethylamine
  • 1-(3,4-Methylenedioxybenzyl)butyl(ethyl)amine
  • 1-(3,4-Methylenedioxybenzyl)butyl(methyl)amine
  • 2-(a-Methyl-3,4-methylenedioxyphenethylamino)ethanol
  • a-Methyl-3,4-methylenedioxyphenethyl(prop-2-ynyl)amine
  • N-Methyl-N-(a-methyl-3,4-methylenedioxyphenethyl)hydroxylamine
  • O-Methyl-N-(a-methyl-3,4-methylenedioxyphenethyl)hydroxylamine
  • a-Methyl-4-(methylthio)phenethylamine
  • b,3,4,5-Tetramethoxyphenethylamine
  • b,2,5-Trimethoxy-4-methylphenethylamine

(c) any compound (not being methoxyphenamine or a compound for the time being specified in sub-paragraph (a) above) structurally derived from phenethylamine an N-alkylphenethylamine, a methylphenethylamine, an N-alkyl-a-methylphenethylamine, a ethylphenethylamine, or an N-alkyl-a-ethylphenethylamine by substitution in the ring to any extent with alkyl, alkoxy, alkylenedioxy or halide substituents, whether or not further substituted in the ring by one or more other univalent substituents.

(d) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from fentanyl by modification in any of the following ways, that is to say,

(i) by replacement of the phenyl portion of the phenethyl group by any heteromonocycle whether or not further substituted in the heterocycle;
(ii) by substitution in the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halogeno, haloalkyl, amino or nitro groups;
(iii) by substitution in the piperidine ring with alkyl or alkenyl groups;
(iv) by substitution in the aniline ring with alkyl, alkoxy, alkylenedioxy, halogeno or haloalkyl groups;
(v) by substitution at the 4-position of the piperidine ring with any alkoxycarbonyl or alkoxyalkyl or acyloxy group;
(vi) by replacement of the N-propionyl group by another acyl group;

(e) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from pethidine by modification in any of the following ways, that is to say,

(i) by replacement of the 1-methyl group by an acyl, alkyl whether or not unsaturated, benzyl or phenethyl group, whether or not further substituted;
(ii) by substitution in the piperidine ring with alkyl or alkenyl groups or with a propano bridge, whether or not further substituted;
(iii) by substitution in the 4-phenyl ring wiith alkyl, alkoxy, aryloxy, halogeno or haloalkyl groups;
(iv) by replacement of the 4-ethoxycarbonyl by any other alkoxycarbonyl or any alkoxyalkyl or acyloxy group;
(v) by formation of an N-oxide or of a quaternary base.

2. Any stereoisomeric form of a substance for the time being specified in paragraph 1 above not being dextromethorphan or dextrorphan.

3. Any ester or ether of a substance for the time being specified in paragraph 1 or 2 above [not being a substance for the time being specified in Part II of this Schedule].

4. Any salt of a substance for the time being specified in any of paragraphs 1 to 3 above.

5. Any preparation or other product containing a substance or product for the time being specified in any of paragraphs 1 to 4 above.

6. Any preparation designed for administration by injection which includes a substance or product for the time being specified in any of paragraphs 1 to 3 of Part II of this Schedule.

Class B drugs

1. The following substances, namely:—

(a)

Name as specified
in the Act↓
Predominant
street name
↓
Drug type
↓
When
added
↓
Notes and comments↓
Acetyldihydrocodeine opioid 1971
Amphetamine speed stimulant 1971
Codeine opioid 1971 intramuscular injection only (legal when in tablet form)
Cannabinol and derivatives cannabinoid 2009 downgraded from class A to class C in 2004 and upgraded to class B in 2009
Cannabis weed Cannabis sativa 2009 All cannabis varieties, including those grown as hemp, are controlled under the act, not just drug varieties
Downgraded from class B to class C in 2004[7] and upgraded to class B in 2009[8]
Dihydrocodeine opioid 1971
Ethylmorphine opioid 1971
Glutethimide sedative 1985
Lefetamine stimulant 1985
Mecloqualone sedative 1984
a-Methylphenethylhydroxylamine 2001
Methaqualone sedative 1984
Methcathinone stimulant 1998
Mephedrone MCAT stimulant 2010
Methylphenidate ritalin stimulant 1971
Methylphenobarbitone sedative 1984
Nicocodeine opioid 1971
Nicodicodine opioid 1973
Norcodeine opioid 1971
Pentazocine opioid 1985
Phenmetrazine stimulant 1971
Pholcodine opioid 1971
Propiram opioid 1973
Zipeprol opioid 1998

(b) any 5,5 disubstituted barbituric acid

(c) [2,3–Dihydro–5–methyl–3–(4–morpholinylmethyl)pyrrolo[1, 2, 3–de]–1,4–benzoxazin–6–yl]–1–naphthalenylmethanone.

3–Dimethylheptyl–11–hydroxyhexahydrocannabinol.

[9–Hydroxy–6–methyl–3–[5–phenylpentan–2–yl] oxy–5, 6, 6a, 7, 8, 9, 10, 10a–octahydrophenanthridin–1–yl] acetate.

9-(Hydroxymethyl)–6, 6–dimethyl–3–(2–methyloctan–2–yl)–6a, 7, 10, 10a–tetrahydrobenzo[c]chromen–1–ol.

Nabilone.

Any compound structurally derived from 3–(1–naphthoyl)indole or 1H–indol–3–yl–(1–naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2–(4–morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent.

Any compound structurally derived from 3–(1–naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2–(4–morpholinyl)ethyl, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent.

Any compound structurally derived from 1–(1–naphthylmethyl)indene by substitution at the 3–position of the indene ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2–(4–morpholinyl)ethyl, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent.

Any compound structurally derived from 3–phenylacetylindole by substitution at the nitrogen atom of the indole ring with alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2–(4–morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent.

Any compound structurally derived from 2–(3–hydroxycyclohexyl)phenol by substitution at the 5–position of the phenolic ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2–(4–morpholinyl)ethyl, whether or not further substituted in the cyclohexyl ring to any extent.”;

2. Any stereoisomeric form of a substance for the time being specified in paragraph 1 of this Part of this Schedule.

3. Any salt of a substance for the time being specified in paragraph 1 or 2 of this Part of this Schedule.

4. Any preparation or other product containing a substance or product for the time being specified in any of paragraphs 1 to 3 of this Part of this Schedule, not being a preparation falling within paragraph 6 of Part I of this Schedule.

Class C drugs

1. The following substances, namely:—

(a)

Name as specified
in the Act↓
Predominant
street name↓
Drug type↓ When
added↓
Notes and comments↓
Alprazolam Xanax benzodiazepine 1996
Aminorex stimulant 1998
Benzphetamine stimulant 1971 metabolized into amphetamine and methamphetamine
Bromazepam benzodiazepine 1996
Brotizolam benzodiazepine 1998
Buprenorphine opioid 1989
Camazepam benzodiazepine 1985
Cathine stimulant 1986
Cathinone stimulant 1986
Chlordiazepoxide Librium benzodiazepine 1985
Chlorphentermine stimulant 1971
Clobazam benzodiazepine 1985
Clorazepic acid benzodiazepine 1985
Clonazepam Klonopin benzodiazepine 1985
Clotiazepam benzodiazepine 1985
Cloxazolam benzodiazepine 1985
Delorazepam benzodiazepine 1985
Dextropropoxyphene opioid 1983
Diazepam valium benzodiazepine 1985
Diethylpropion stimulant 1984
Estazolam benzodiazepine 1985
Ethchlorvynol sedative 1985
Ethinamate sedative 1985
Ethyl loflazepate benzodiazepine 1985
Fencamfamine stimulant 1971 Removed from the schedule in 1973, added to the schedule again in 1986
Fenethylline stimulant 1986
Fenproporex stimulant 1986
Fludiazepam benzodiazepine 1985
Flunitrazepam rohypnol benzodiazepine 1985
Flurazepam benzodiazepine 1985
gamma-Butyrolactone GBL sedative 2009 Metabolised to GHB in the body. Classified in Dec 2009[10]
Halazepam benzodiazepine 1985
Haloxazolam benzodiazepine 1985
4-Hydroxy-n-butyric acid GHB sedative 2003
Ketamine ket sedative 2006
Ketazolam benzodiazepine 1985
Loprazolam benzodiazepine 1985
Lorazepam benzodiazepine 1985
Lormetazepam benzodiazepine 1985
Mazindol stimulant 1985
Medazepam benzodiazepine 1985
Mefenorex stimulant 1986 amphetamine derivative, metabolises to amphetamine
Mephentermine stimulant 1971
Meprobamate sedative 1985
Mesocarb stimulant 1998 used to counteract the effects of benzodiazepines
Methyprylone sedative 1985
Midazolam benzodiazepine 1990
Nimetazepam benzodiazepine 1985
Nitrazepam benzodiazepine 1985
Nordazepam benzodiazepine 1985
Oxazepam benzodiazepine 1985
Oxazolam benzodiazepine 1985
Pemoline stimulant 1989
Phendimetrazine stimulant 1971
Phentermine stimulant 1985
Pinazepam benzodiazepine 1985
Pipradrol stimulant 1971
Propylhexedrine stimulant 1971 legalised in 1995
Prazepam benzodiazepine 1985
Pyrovalerone stimulant 1986
Temazepam benzodiazepine 1985 becomes class A when prepared for injection
Tetrazepam benzodiazepine 1985
Triazolam benzodiazepine 1985
N-Ethylamphetamine stimulant 1986
Zolpidem 2003
N.B. Sub-paragraphs (b), (c), (d) and (e) all refer to anabolic steroids that were banned in 1996[13] (unless referenced otherwise):

(b)

(c) any compound (not being Trilostane or a compound for the time being specified in sub-paragraph (b) above) structurally derived from 17-hydroxyandrostan-3-one or from 17-hydroxyestran-3-one by modification in any of the following ways, that is to say, (i) by further substitution at position 17 by a methyl or ethyl group; (ii) by substitution to any extent at one or more of positions 1, 2, 4, 6, 7, 9, 11 or 16, but at no other position; (iii) by unsaturation in the carbocyclic ring system to any extent, provided that there are no more than two ethylenic bonds in any one carbocyclic ring; (iv) by fusion of ring A with a heterocyclic system;

(d) any substance which is an ester or ether (or, where more than one hydroxyl function is available, both an ester and an ether) of a substance specified in sub-paragraph (b) or described in sub-paragraph (c) above;

(e)

(f) 1–benzylpiperazine or any compound (not being 1–(3–chlorophenyl)piperazine or 1–(3–chlorophenyl)–4–(3–chloropropyl)piperazine) structurally derived from 1–benzylpiperazine or 1–phenylpiperazine by modification in any of the following ways

(i) by substitution at the second nitrogen atom of the piperazine ring with alkyl, benzyl, haloalkyl or phenyl groups;

(ii) by substitution in the aromatic ring to any extent with alkyl, alkoxy, alkylenedioxy, halide or haloalkyl groups;

2. Any stereoisomeric form of a substance for the time being specified in paragraph 1 of this Part of this Schedule [not being phenylpropanolamine.]

3. Any salt of a substance for the time being specified in paragraph 1 or 2 of this Part of this Schedule.

4. Any preparation or other product containing a substance for the time being specified in any of paragraphs 1 to 3 of this Part of this Schedule.

References

  1. ^ a b c “Misuse of Drugs Act 1971 (c. 38): SCHEDULE 2: Controlled Drugs”. Office of Public Sector Information. Retrieved 2009-06-15.
  2. ^ a b c d e f g h “The Misuse of Drugs Act 1971 (Modification) Order 2003”. Office of Public Sector Information. Retrieved 2009-06-15.
  3. ^ a b c d e f “The Misuse of Drugs Act 1971 (Modification) Order 1998”. Office of Public Sector Information. Retrieved 2009-06-15.
  4. ^ “Misuse of Drugs Act 1971 (Amendment) Order 2006”. Office of Public Sector Information. Retrieved 2009-06-15.
  5. ^ “Drugs Act 2005 (c. 17)”. Office of Public Sector Information. Retrieved 2009-06-15.
  6. ^ a b “The Misuse of Drugs Act 1971 (Modification) Order 2001”. Office of Public Sector Information. Retrieved 2009-06-15.
  7. ^ a b “The Misuse of Drugs Act 1971 (Modification)(No. 2) Order 2003”. Office of Public Sector Information. Retrieved 2009-06-15.
  8. ^ a b “The Misuse of Drugs Act 1971 (Amendment) Order 2008”. Office of Public Sector Information. Retrieved 2009-06-15.
  9. ^ Mephedrone ban comes into force in UK
  10. ^ The Misuse of Drugs Act 1971 (Amendment) Order 2009 http://www.opsi.gov.uk/si/si2009/draft/ukdsi_9780111486610_en_1
  11. ^ “The Misuse of Drugs Act 1971 (Amendment) Order 2005”. Office of Public Sector Information. Retrieved 2009-06-15.
  12. ^ “The Misuse of Drugs Act 1971 (Modification) Order 1995”. Office of Public Sector Information. Retrieved 2009-06-15.
  13. ^ “The Misuse of Drugs Act 1971 (Modification) Order 1996”. Office of Public Sector Information. Retrieved 2009-06-15.
Advertisements